Mirae Asset Global Investments Co., Ltd. Prometheus Biosciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
BUY
$103.46 - $126.29 $264,133 - $322,418
2,553 Added 15.91%
18,604 $2 Million
Q4 2022

Feb 09, 2023
BUY
$36.06 - $117.21 $80,810 - $262,667
2,241 Added 16.23%
16,051 $1.77 Million
Q3 2022

Nov 10, 2022
BUY
$28.17 - $59.01 $105,947 - $221,936
3,761 Added 37.43%
13,810 $815,000
Q2 2022

Jul 26, 2022
BUY
$22.39 - $38.94 $224,997 - $391,308
10,049 New
10,049 $283,000

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email